arsenic has been researched along with Medulloblastoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shehri, A; Couraud, PO; Favretto, ME; Ioannou, PV; Kallinteri, P; Parker, TL; Romero, IA; Weksler, BB | 1 |
| Andrade, AF; Delsin, LE; Klinger, PH; Queiroz, RG; Scrideli, CA; Tone, LG; Valera, ET | 1 |
| Antimisiaris, SG; Favretto, ME; Ioannou, P; Kallinteri, P; Marouf, S; Parker, TL | 1 |
| Beachy, PA; Gardner, D; Kim, J; Lee, JJ | 1 |
| Raju, GP | 1 |
| Albanese, C; Beauchamp, EM; Bulut, G; Hall, MD; Lee, YC; Macdonald, TJ; Ozdemirli, M; Peaceman, D; Ringer, L; Rodriguez, O; Sajwan, KP; Toretsky, JA; Uren, A | 1 |
| Amano, S; Gao, Y; Gu, C; Koizumi, S; Namba, H; Tokuyama, T; Yokota, N | 1 |
| Beauchamp, EM; Uren, A | 1 |
| Aftab, BT; Beachy, PA; Borodovsky, A; Chen, B; Epstein, EH; Kim, D; Kim, J; King, EM; Lee, AH; Rezaee, M; Riggins, GJ; Rudin, CM; Tang, JY | 1 |
2 review(s) available for arsenic and Medulloblastoma
| Article | Year |
|---|---|
Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.
Topics: Adolescent; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cerebellar Neoplasms; Child; Child, Preschool; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Infant; Medulloblastoma; Oxides; Signal Transduction | 2017 |
A new era for an ancient drug: arsenic trioxide and Hedgehog signaling.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Leukemia, Promyelocytic, Acute; Medulloblastoma; Oncogene Proteins; Oxides; Sarcoma, Ewing | 2012 |
7 other study(ies) available for arsenic and Medulloblastoma
| Article | Year |
|---|---|
Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Topics: Antibodies; Antineoplastic Agents; Apoptosis; Arsenicals; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Chemistry, Pharmaceutical; Coculture Techniques; Endothelial Cells; Humans; Immunoconjugates; Liposomes; Medulloblastoma; Polyethylene Glycols; Receptors, Transferrin; Technology, Pharmaceutical | 2015 |
Arsonoliposomes for the potential treatment of medulloblastoma.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Arsenicals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Endocytosis; Liposomes; Medulloblastoma; Mice; Treatment Outcome | 2009 |
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.
Topics: Animals; Arsenic Trioxide; Arsenicals; Arsenites; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Hedgehog Proteins; Kruppel-Like Transcription Factors; Luciferases; Luminescent Proteins; Medulloblastoma; Mice; Mice, Knockout; Mice, Nude; Neoplasms, Experimental; NIH 3T3 Cells; Oxides; Protein Stability; Recombinant Fusion Proteins; Signal Transduction; Sodium Compounds; Transfection; Transplantation, Homologous; Tumor Suppressor Protein p53; Zinc Finger Protein Gli2 | 2010 |
Arsenic: a potentially useful poison for Hedgehog-driven cancers.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Hedgehog Proteins; Humans; Medulloblastoma; Mice; Models, Biological; Neoplasms; Oxides; Receptors, G-Protein-Coupled; Sarcoma, Ewing; Signal Transduction; Smoothened Receptor; Transcription Factors; Zinc Finger Protein GLI1 | 2011 |
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Base Sequence; Cell Line, Tumor; DNA Primers; Gene Expression; Hedgehog Proteins; Hep G2 Cells; Humans; Medulloblastoma; Mice; Mice, SCID; Mice, Transgenic; Neoplasm Transplantation; Oncogene Proteins; Oxides; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Sarcoma, Ewing; Signal Transduction; Smoothened Receptor; Trans-Activators; Transplantation, Heterologous; Zinc Finger Protein GLI1 | 2011 |
Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.
Topics: Animals; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cerebellar Neoplasms; Cytarabine; Humans; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasms, Experimental; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 2012 |
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.
Topics: Anilides; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Hedgehog Proteins; Itraconazole; Medulloblastoma; Mice; Oxides; Pyridines; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor | 2013 |